Zika Virus Tied to Potential Brain Damage in Newborns
By LabMedica International staff writers Posted on 11 Jan 2016 |
Image: The female Aedes aegypti mosquito that transmits the Zika virus (Photo courtesy of James Gathany/CDC).
Image: Non-purulent viral conjunctivitis or red eye with no pus, a symptom of Zika virus infection (Photo courtesy of Brazilian Ministry of Health).
The Brazilian authorities are investigating thousands of suspected cases of microcephaly in babies born to mothers infected with the mosquito-borne Zika virus, while they were pregnant.
Zika is a virus that is transmitted by the same Aedes mosquito that spreads dengue and chikungunya and infected people have clinical symptoms similar to those illnesses and it is possible that some suspected cases of dengue could be Zika.
Scientists at the Ministry of Health (Brasilia, Brazil) have been investigating potential links between Zika virus infection in pregnancy and fetal microcephaly since October 2015, when they reported an unusual surge in cases of microcephaly in newborns following a Zika virus outbreak in the northeastern states. Up to December 12, 2015, the Brazilian ministry had been notified of 2,401 suspected cases of microcephaly linked to Zika virus infection in pregnancy. Of these, 2,165 are under investigation, 134 have been confirmed and 102 have been discarded.
The most common symptoms of Zika infection are mild fever, rash, headache, joint pain and non-purulent conjunctivitis, which is red eye with no pus. One out of four people may not develop symptoms, but those who do, experience them from two to seven days. Severe disease requiring hospitalization is uncommon. A baby born with microcephaly has a smaller-than-normal head, caused by abnormal brain growth or because the brain stops growing. The brain fails to grow as the infant develops, and the condition often results in serious neurological and development problems and sometimes early death.
By December 22, 2015, a team at the Institute of Biomedical Sciences (ICB) at the University of Sao Paulo (Brazil) had already developed cultures for growing Zika in cells, a necessary first step for experiments and for obtaining diagnoses via DNA. Within a month, they expect to have a blood test for diagnosing Zika that is cheaper and easier than a DNA test. Angela Rocha, MD a pediatric infectologist, said, “It's a very personal decision, but at this moment of uncertainty, if families can put off their pregnancy plans, that's what we're recommending."
Related Links:
Brazilian Ministry of Health
University of São Paulo
Zika is a virus that is transmitted by the same Aedes mosquito that spreads dengue and chikungunya and infected people have clinical symptoms similar to those illnesses and it is possible that some suspected cases of dengue could be Zika.
Scientists at the Ministry of Health (Brasilia, Brazil) have been investigating potential links between Zika virus infection in pregnancy and fetal microcephaly since October 2015, when they reported an unusual surge in cases of microcephaly in newborns following a Zika virus outbreak in the northeastern states. Up to December 12, 2015, the Brazilian ministry had been notified of 2,401 suspected cases of microcephaly linked to Zika virus infection in pregnancy. Of these, 2,165 are under investigation, 134 have been confirmed and 102 have been discarded.
The most common symptoms of Zika infection are mild fever, rash, headache, joint pain and non-purulent conjunctivitis, which is red eye with no pus. One out of four people may not develop symptoms, but those who do, experience them from two to seven days. Severe disease requiring hospitalization is uncommon. A baby born with microcephaly has a smaller-than-normal head, caused by abnormal brain growth or because the brain stops growing. The brain fails to grow as the infant develops, and the condition often results in serious neurological and development problems and sometimes early death.
By December 22, 2015, a team at the Institute of Biomedical Sciences (ICB) at the University of Sao Paulo (Brazil) had already developed cultures for growing Zika in cells, a necessary first step for experiments and for obtaining diagnoses via DNA. Within a month, they expect to have a blood test for diagnosing Zika that is cheaper and easier than a DNA test. Angela Rocha, MD a pediatric infectologist, said, “It's a very personal decision, but at this moment of uncertainty, if families can put off their pregnancy plans, that's what we're recommending."
Related Links:
Brazilian Ministry of Health
University of São Paulo
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia